Drug Evaluation Committee Symposium for pharmaceutical companies on "Drug Development Based on Patients' Voices
Oct. 27, 2021
- 0_Program (353KB)
- 1_Activities by the Pharmaceutical Cooperative Task Force (2.5MB)
- 2. Background and Significance of Patient Involvement in Drug Development (1.8MB)
- 3. From the Regulatory Authority's Standpoint (2.0MB)
- 4. Initiatives by Medical Institutions (9.7MB)
- 5. Expectations of Pharmaceutical Companies from Patients' Perspective (1) (6.4MB)
- 6. Expectations of Pharmaceutical Companies from the Patient's Standpoint (2) (254KB)
- 7. Establishment of Internal System (0.9MB)
- 8_Patient Review of Protocol ICF (0.7MB)
- 9_Patient lecture meeting (1.3MB)